Demain Arnold L, Martens Evan
Research Institute for Scientists Emeriti (RISE), Drew University, Madison, NJ, USA.
Cempra, Chapel Hill, NC, USA.
J Antibiot (Tokyo). 2017 Apr;70(4):347-360. doi: 10.1038/ja.2016.121. Epub 2016 Oct 12.
We are pleased to dedicate this paper to Dr Julian E Davies. Julian is a giant among microbial biochemists. He began his professional career as an organic chemistry PhD student at Nottingham University, moved on to a postdoctoral fellowship at Columbia University, then became a lecturer at the University of Manchester, followed by a fellowship in microbial biochemistry at Harvard Medical School. In 1965, he studied genetics at the Pasteur Institute, and 2 years later joined the University of Wisconsin in the Department of Biochemistry. He later became part of Biogen as Research Director and then President. After Biogen, Julian became Chair of the Department of Microbiology at the University of British Columbia in Vancouver, Canada, where he has contributed in a major way to the reputation of this department for many years. He also served as an Adjunct Professor at the University of Geneva. Among Julian's areas of study and accomplishment are fungal toxins including α-sarcin, chemical synthesis of triterpenes, mode of action of streptomycin and other aminoglycoside antibiotics, biochemical mechanisms of antibiotic resistance in clinical isolates of bacteria harboring resistance plasmids, their origins and evolution, secondary metabolism of microorganisms, structure and function of bacterial ribosomes, antibiotic resistance mutations in yeast ribosomes, cloning of resistance genes from an antibiotic-producing microbe, gene cloning for industrial purposes, engineering of herbicide resistance in useful crops, bleomycin-resistance gene in clinical isolates of Staphylococcus aureus and many other topics. He has been an excellent teacher, lecturing in both English and French around the world, and has organized international courses. Julian has also served on the NIH study sections, as Editor for several international journals, and was one of the founders of the journal Plasmid. We expect the impact of Julian's accomplishments to continue into the future.
我们很高兴将此论文献给朱利安·E·戴维斯博士。朱利安是微生物生物化学领域的巨擘。他的职业生涯始于诺丁汉大学的有机化学博士生,之后在哥伦比亚大学做博士后研究员,接着成为曼彻斯特大学的讲师,随后在哈佛医学院获得微生物生物化学领域的奖学金。1965年,他在巴斯德研究所研究遗传学,两年后加入威斯康星大学的生物化学系。后来他成为百健公司的研究总监,之后担任总裁。离开百健后,朱利安成为加拿大温哥华英属哥伦比亚大学微生物学系主任,多年来他为该系声誉的提升做出了重大贡献。他还担任日内瓦大学的兼职教授。朱利安的研究领域和成就包括真菌毒素(如α-肌动蛋白)、三萜类化合物的化学合成、链霉素和其他氨基糖苷类抗生素的作用机制、携带耐药质粒的临床分离细菌中抗生素耐药性的生化机制、其起源和进化、微生物的次生代谢、细菌核糖体的结构和功能、酵母核糖体中的抗生素耐药性突变、从抗生素产生菌中克隆耐药基因、用于工业目的的基因克隆、在有用作物中培育除草剂抗性、金黄色葡萄球菌临床分离株中的博来霉素耐药基因以及许多其他主题。他是一位优秀的教师,在世界各地用英语和法语授课,并组织国际课程。朱利安还曾在美国国立卫生研究院的研究小组任职,担任过几本国际期刊的编辑,并且是《质粒》杂志的创始人之一。我们预计朱利安的成就将在未来持续产生影响。